Artificial Intelligence in Medical Imaging Market - Global Forecast 2025-2032

The artificial intelligence in medical imaging market is transforming healthcare diagnostics by offering enhanced workflow efficiency, improved accuracy, and innovative solutions for complex clinical scenarios. As AI technologies become more integrated across the imaging landscape, senior decision-makers are evaluating adoption strategies to optimize performance and manage regulatory requirements.

Market Snapshot: Artificial Intelligence in Medical Imaging Market

The artificial intelligence in medical imaging market is experiencing rapid expansion, propelled by increasing investments in digital health technologies, strategic partnerships, and the demand for streamlined diagnostic processes. The market’s notable growth trajectory—from USD 2.25 billion in 2024 to USD 2.87 billion in 2025—reflects strong momentum, with projected continued robust gains and a CAGR of 28.64%. Key factors include advances in machine learning, effective integration of AI capabilities with electronic health records, and evolving reimbursement structures. These trends are fostering greater efficiency within medical facilities, contributing to clinical value and competitive differentiation across regions.

Scope & Segmentation: Comprehensive Market Coverage

• Component: Hardware, Services including Managed Services and Professional Services, and dedicated Software supporting medical imaging workflows.
• Imaging Technology: CT Scanners, MRI Systems, Ultrasound Devices, and X-ray Systems contribute to a diverse imaging technology landscape, each enabling tailored AI applications.
• Application: AI algorithms address a range of clinical areas, spanning Cardiology, Neurology, Oncology, Pathology, and Radiology, enabling more informed diagnostic and treatment decisions.
• End-User: Solutions are adopted by Academic & Research Institutions, Diagnostic Centers, and Hospitals & Clinics, reflecting varied requirements for integration, scalability, and workflow optimization.
• Region: The market encompasses the Americas, Europe, Middle East, Africa, and Asia-Pacific, with major economies and regional healthcare hubs driving innovation and adoption across each territory. Countries such as the United States, Germany, the United Kingdom, China, and India are at the forefront of regional advances.
• Key Companies: Market leadership is shaped by a spectrum of organizations including aetherAI, Agfa-Gevaert Group, Behold.ai Technologies Limited, Brainomix Limited, Butterfly Network Inc., Cancer Center.ai, CureMetrix Inc., Dr CADx, EchoNous Inc., Enlitic Inc., Fujifilm Holdings Corporation, GE Healthcare, Intelerad Medical Systems Incorporated, Koninklijke Philips N.V., Nano-X Imaging Ltd., Nuance Communications Inc., NVIDIA Corporation, RetinAI, Shanghai United Imaging Healthcare Co. LTD, Siemens Healthineers AG, SigTuple Technologies, Subtle Medical, Tempus AI Inc, Volpara Health Technologies Ltd., and Brainminer Ltd.

Key Takeaways for Senior Decision-Makers

• AI-enabled imaging unlocks earlier and more precise detection of complex diseases, reducing clinician workload and contributing to enhanced patient outcomes.
• Cloud-based and interoperable platforms foster better cross-disciplinary collaboration and efficient aggregation of imaging data, strengthening healthcare networks.
• Hospitals and clinics value integrated AI solutions for seamless workflows, while diagnostic centers often prioritize rapid implementation and scalable, modular platforms.
• AI applications demonstrate particular value in oncology, cardiology, and neurology, supporting advanced lesion identification, brain mapping, and comprehensive cardiac analysis.
• Industry leaders, technology start-ups, and academic partners are accelerating the acceptance of AI imaging by co-developing validated, practical diagnostic tools.
• Strong investment in workforce training and open ecosystem platforms is essential for imaging teams seeking to adapt to more sophisticated operational frameworks.

Tariff Impact: Navigating Economic and Supply Chain Pressures

Ongoing U.S. tariffs on imported medical imaging components are shifting cost structures for manufacturers and service providers. This environment is encouraging domestic production and near-shoring of critical hardware, while prompting greater investment in software-driven and cloud-delivered imaging platforms. As costs are carefully managed, strategic partnerships are pivotal for maintaining standards in image quality, regulatory compliance, and technology access in a price-sensitive market.

Methodology & Data Sources

The report draws from primary interviews with radiologists, industry and regulatory experts, and hospital administrators across key regions. Findings are supported by secondary research, including peer-reviewed literature, technical white papers, regulatory documentation, and industry conferences. Insights are validated through data triangulation, expert review, and real-world case studies.

Why This Report Matters

• Supports the development of strategies that navigate technology, regulatory, and operational changes in the artificial intelligence in medical imaging market.
• Informs investment decisions by mapping emerging opportunities by region, application area, and key technology provider.
• Enables prioritization of interoperability, robust data governance, and workforce readiness in an evolving medical imaging value chain.

Conclusion

By aligning with market trends and pursuing scalable AI imaging investments, senior decision-makers can build greater resilience and deliver sustainable improvements in patient care and operational performance.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.